Research Reports | Market Assessment
December 2020

Immune Checkpoint Inhibitors: Trends and Market Dynamics | Special Topics | G7 – 2020

Immune checkpoint inhibitors have demonstrated their efficacy in the treatment of a broad range of tumor types, establishing the drug class as a versatile weapon against cancer. The approval of agents targeting checkpoint blockade continues to transform the treatment paradigm for many oncology indications at an incredible rate. This Special Topics report provides a comprehensive market forecast of current and emerging immune checkpoint inhibitors and analyzes the market trends and dynamics in a range of oncology indications.

QUESTIONS ANSWERED

  • What is the timeline and current landscape for approved immune checkpoint inhibitors? What are the trends in each key oncology indication?
  • How will emerging immune checkpoint inhibitors be positioned in the market? How will the indication-specific market trends and dynamics evolve?
  • What is the commercial potential of current and emerging immune checkpoint inhibitors by brand, indication, combination type, and geography? How will the market evolve over the 2020-2030 forecast period?

GEOGRAPHIES

United States, EU5, Japan.

EPIDEMIOLOGY

Drug-treated patient populations by brand, indication, combination type, and geography for indications for which immune checkpoint inhibitors are approved or forecast for approval.

FORECAST

10-year, annualized, drug-level sales of immune checkpoint inhibitors through 2030, segmented by indication, combination type, and geography.

KEY DRUGS COVERED

Currently approved agents targeting PD-1, PD-L1, and CTLA-4.

EMERGING THERAPIES

Phase III/PR.

PRODUCT DESCRIPTION

Clarivate’s Special Topics reports assess key trends in dynamic disease areas. This report offers a comprehensive market forecast of the immune checkpoint inhibitor landscape in relevant oncology indications

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports